Endo, Inc. is a pharmaceutical company, which boldly transforming insights into life-enhancing therapies. The firm products include medicines, sterile injectables, generics, ready-to-use products. It focuses on research & development (R&D), grants, clinical research, pipeline and R&D approach. The company is headquartered in Malvern, PA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company